Surgical Care Affiliates Inc (SCAI) reported quarterly earnings results on Tuesday, May-3-2016. The company reported $0.27 earnings per share for the quarter, missing the analyst consensus estimate by $-0.09. Analysts had a consensus of $0.36. The company posted revenue of $279.70 million in the period, compared to analysts expectations of $272.23 million. The company’s revenue was up 19.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.39 EPS.
Surgical Care Affiliates Inc opened for trading at $48.08 and hit $48.71 on the upside on Monday, eventually ending the session at $48.58, with a gain of 0.48% or 0.23 points. The heightened volatility saw the trading volume jump to 3,62,918 shares. Company has a market cap of $1,931 M.
In a different news, on Apr 26, 2016, Andrew P Hayek (Chief Executive Officer) sold 13,468 shares at $48.17 per share price. According to the SEC, on Mar 4, 2016, Michael A. Rucker (Chief Operating Officer) sold 17,500 shares at $41.60 per share price. On Feb 26, 2016, Thomas C Geiser (director) sold 11,256 shares at $41.07 per share price, according to the Form-4 filing with the securities and exchange commission.
Surgical Care Affiliates Inc. (Surgical Care Affiliates) is a national provider of solutions to physicians health systems and payors. The Company operates a network of outpatient surgery facilities in the United States which as of December 31 2014 consisted of 179 ambulatory surgery centers (ASCs) six surgical hospitals and one sleep center with 11 locations. Surgical Care Affiliates offers tools and systems in the areas of clinical benchmarking clinical best practices operating efficiency care coordination and supply chain management. Surgical Care Affiliates’ network of facilities includes ASCs surgical hospitals and hospital surgery departments. As of December 31 2014 Surgical Care Affiliates owned and operated facilities in partnership with 42 health systems and approximately 2000 physician partners. As of December 31 2014 case mix in the Company’s portfolio included orthopedic ophthalmology gastroenterology ENT pain and general surgery.